Delivery Order SPE2DB25D3008-SPE2DB25FRDAE
Award Date 8/20/25
Potential Completion Date 9/11/25
Potential Value $4.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for Zeposia 0.92 mg capsules (30-count units) under a firm fixed-price contract valued at $13,862.79. This non-set-aside competitive award, with an ultimate completion date of August 18, 2025, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units) with a ceiling value of $9,241.86. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award supporting federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $13.86K delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units). This is a firm fixed price contract with no set-aside designation, scheduled for completion by September 2, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026 that...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,620.93 by the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Zeposia 0.92 mg capsules (30-count packaging). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 19, 2025. The contract will be performed at AmerisourceBergen's Conshohocken facility. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 mg capsules (30-count units) under a firm fixed-price contract valued at $4,620.93, with an ultimate completion date of August 13, 2025. This non-set-aside competitive award reflects AmerisourceBergen's capability to deliver pharmaceutical products to support federal medical procurement needs. The contract is executed out of the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $13,862.79 to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 mg capsules (30-count units) under a firm fixed-price contract. The award was issued on July 29, 2025, with an ultimate completion date of August 19, 2025, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp will perform the delivery from its corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Zeposia 0.92 mg capsules (30-count) with a ceiling value of $13,862.79. This firm fixed-price delivery order represents a non-competitive award and is scheduled for completion by August 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a leading pharmaceutical distributor, AmerisourceBergen maintains a...
- The Defense Logistics Agency awarded a $13,862.79 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units). This is a firm fixed-price contract with an ultimate completion date of August 20, 2025, and represents a non-competitive set-aside delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed and delivered from the company's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,620.93 to supply 30 capsules of Zeposia 0.92 mg, a pharmaceutical product used in the treatment of multiple sclerosis and other immune-mediated conditions. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by September 5, 2025. The contract is being performed from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $13,862.79 to AmerisourceBergen Drug Corp for Zeposia 0.92 mg capsules (30-count) on July 24, 2025, with an ultimate completion date of August 14, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs. This delivery order...